Our study reveals a novel mechanistic link in which curcumin suppresses PTBP1 expression by targeting the CDK2–c-MYC signaling axis, uncovering a previously uncharacterized regulatory pathway in CRC. Here, CDK2 is linked to colorectal carcinoma.